Tuesday, Mar 28 2017 | Time 07:57 Hrs(IST)
image
  • TV PROGRAMME DD SPORTS
  • TV PROGRAMME DD NATIONAL
  • Trump son-in-law met executives of sanctioned Russian bank; will testify
  • Weaker dollar lifts oil futures, but soaring US output weighs
  • Australia shares bounces back as investors shift focus back home; NZ slips
  • Australia cancels vote on extradition treaty with China
  • Venezuela to create new exchange rate mechanism - President Maduro
  • China's Liaoning pledges 10 mln T low-grade steel closures by June
  • NZ extend lead after Williamson dismissed in third test
  • House Democratic leader Pelosi says intel panel chief should recuse himself
  • Dollar limps away from multi-month lows, still seen vulnerable
  • China can deploy warplanes on artificial islands any time -think tank
  • Senegal-Ivory Coast friendly abandoned after pitch invasion
  • US government watchdog to review Mar-a-Lago trips, Trump hotel profits
  • Montenegro NATO accession clears hurdle in US Senate
Science & Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.
The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers.
Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies.
Over 35 oncologists in India have already screened patients using our Oncotrack.
Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.
' India is likely to have over 1.
73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020.
Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low.
'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies.
We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome.
The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country.
The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood.
Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers.
The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.
This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option.
Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment.
The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre.
UNI ST SS RSA SB 1043

Mah

Mah young scientists make place in world competition Google Lunar X Prize

Kolhapur, Mar 26 (UNI) Three young scientists from the city have made their place in the world competition "Google Lunar X Prize" with the idea of an "Electrostatic Active Radiation Shield" (EARS).

Mah

Mah young scientists make place in world competition Google Lunar X Prize

Kolhapur, Mar 26 (UNI) Three young scientists from the city have made their place in the world competition "Google Lunar X Prize" with the idea of an "Electrostatic Active Radiation Shield" (EARS).

Cytoreductive

Cytoreductive Surgery performed at Jipmer

Puducherry, Mar 16 (UNI) In an effort to provide the state of the art health services to the underprivileged, JIPMER has moved a step forward by performing its first Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Department of Surgical Oncology.

Cytoreductive

Cytoreductive Surgery performed at Jipmer

Puducherry, Mar 16 (UNI) In an effort to provide the state of the art health services to the underprivileged, JIPMER has moved a step forward by performing its first Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Department of Surgical Oncology.

Miniature

Miniature lab begins science experiments in outer space

HERZLIYA, Israel, Mar 16 (Reuters) Orbiting the earth at more than 500 kilometres, a tiny satellite with a laboratory shrunk to the size of a tissue box is helping scientists carry out experiments that take gravity out of the equation.

Miniature

Miniature lab begins science experiments in outer space

HERZLIYA, Israel, Mar 16 (Reuters) Orbiting the earth at more than 500 kilometres, a tiny satellite with a laboratory shrunk to the size of a tissue box is helping scientists carry out experiments that take gravity out of the equation.

MedGenome

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.

MedGenome

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring.

Lupin

Lupin launches Generic Paxil CR tablets in the US

Mumbai,Mar 7(UNI) Pharma Major Lupin Limited (Lupin) announced today the launch of generic Paxil CR (Paroxetin) Extended Release Tablets USP, 12.

Lupin

Lupin launches Generic Paxil CR tablets in the US

Mumbai,Mar 7(UNI) Pharma Major Lupin Limited (Lupin) announced today the launch of generic Paxil CR (Paroxetin) Extended Release Tablets USP, 12.

Nano-particle fertilizer could lead to new 'green revolution'

Nano-particle fertilizer could lead to new 'green revolution'

New Delhi, Jan 26 (UNI) Sri Lankan scientists report having developed a simple way to make a benign, more efficient fertilizer – described as nano-particle fertilizer - that could contribute to a second food revolution across the globe.

Broken pebbles offer clues to Palaeolithic funeral rituals

Broken pebbles offer clues to Palaeolithic funeral rituals

New Delhi, Feb 9 (UNI) Humans may have ritualistically "killed" objects to remove their symbolic power, some 5,000 years earlier than previously thought, a new international study of marine pebble tools from an Upper Palaeolithic burial site in Italy suggests.

Fiscal incentives may help reduce emissions in developing countries

Fiscal incentives may help reduce emissions in developing countries

New Delhi, Feb 7 (UNI) Fiscal policies introduced by the Governments in developing countries can have a significant effect on lowering harmful carbon emissions and help countries with fulfilling their commitments under the UNFCCC Paris Agreement, a study has found.

image